Bedogni Francesco, Frigiola Alessandro, Ranucci Marco, Brambilla Nedy, Montone Rocco Antonio, Agnifili Mauro, Menicanti Lorenzo, Testa Luca
Coronary Revascularisation Unit, IRCCS Policlinico S. Donato, S. Donato Milanese, piazza E. Malan, Milan, Italy.
Eur Heart J Suppl. 2016 Apr 28;18(Suppl E):E86-E95. doi: 10.1093/eurheartj/suw017. Epub 2016 Apr 29.
Transcatheter aortic valve replacement determined a paradigm shift in the treatment of high-risk patients with severe symptomatic aortic valve stenosis. Notwithstanding the impressive results of the first-generation prostheses, a fast-paced technological evolution is taking place to overcome their limitations, in particular the vascular access damage and the paravalvular leak. Nowadays, with the availability of several different devices, the expert operator can select the right prosthesis for the specific anatomical and clinical situation. As 'One does not fit all', the 'Tailored TAVR Approach' we describe will conceivably become the future of this therapy.
经导管主动脉瓣置换术在高危重症症状性主动脉瓣狭窄患者的治疗中引发了范式转变。尽管第一代人工瓣膜取得了令人瞩目的成果,但为克服其局限性,尤其是血管通路损伤和瓣周漏,一场快节奏的技术变革正在发生。如今,有多种不同的器械可供使用,经验丰富的操作人员能够针对特定的解剖和临床情况选择合适的人工瓣膜。由于“一种方案并不适用于所有人”,我们所描述的“定制经导管主动脉瓣置换术方法”有望成为这种治疗方法的未来发展方向。